Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Buschauer

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Archiv Der Pharmazie|October 1, 1995
4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activityD Glass, A Buschauer, H Tenor, et al.
Molecular Pharmacology|November 28, 2001
Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonistsM T Kelley, T Bürckstümmer, K Wenzel-Seifert, et al.
Shock (Augusta, Ga.)|July 1, 1994
Beneficial effect of H2-agonism and H1-antagonism in rat endotoxic shockD Rixen, E Neugebauer, A Lechleuthner, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|April 25, 2000
Absolute configuration of (-)-4-(3,4-dichlorophenyl)-4-(2-pyridyl)butanoic acid: essential information to determine crucial steric features of arpromidine-type histamine H2 receptor agonistsM Zabel, J Breu, F Rau, et al.
Journal of Medicinal Chemistry|June 12, 1992
Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptorJ Hirschfeld, A Buschauer, S Elz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2001
Programmable biodegradable implantsW Vogelhuber, P Rotunno, E Magni, et al.
Journal of Nanoscience and Nanotechnology|April 17, 2014
Biodistribution of quantum dots in the kidney after intravenous injectionK Pollinger, R Hennig, S Bauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probesM Ruat, E Traiffort, M L Bouthenet, et al.
British Journal of Pharmacology|June 7, 2014
Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutantsD Wifling, K Löffel, U Nordemann, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1994
Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadineJ Kleine-Tebbe, C Josties, G Frank, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Archiv Der Pharmazie|October 1, 1995
4-(4-Guanidinobenzoyl)-2-imidazolones and related compounds: phosphodiesterase inhibitors and novel cardiotonics with combined histamine H2 receptor agonist and PDE III inhibitor activityD Glass, A Buschauer, H Tenor, et al.
Molecular Pharmacology|November 28, 2001
Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonistsM T Kelley, T Bürckstümmer, K Wenzel-Seifert, et al.
Shock (Augusta, Ga.)|July 1, 1994
Beneficial effect of H2-agonism and H1-antagonism in rat endotoxic shockD Rixen, E Neugebauer, A Lechleuthner, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|April 25, 2000
Absolute configuration of (-)-4-(3,4-dichlorophenyl)-4-(2-pyridyl)butanoic acid: essential information to determine crucial steric features of arpromidine-type histamine H2 receptor agonistsM Zabel, J Breu, F Rau, et al.
Journal of Medicinal Chemistry|June 12, 1992
Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptorJ Hirschfeld, A Buschauer, S Elz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 5, 2001
Programmable biodegradable implantsW Vogelhuber, P Rotunno, E Magni, et al.
Journal of Nanoscience and Nanotechnology|April 17, 2014
Biodistribution of quantum dots in the kidney after intravenous injectionK Pollinger, R Hennig, S Bauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 1990
Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probesM Ruat, E Traiffort, M L Bouthenet, et al.
British Journal of Pharmacology|June 7, 2014
Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutantsD Wifling, K Löffel, U Nordemann, et al.
The Journal of Allergy and Clinical Immunology|February 1, 1994
Inhibition of IgE- and non-IgE-mediated histamine release from human basophil leukocytes in vitro by a histamine H1-antagonist, desethoxycarbonyl-loratadineJ Kleine-Tebbe, C Josties, G Frank, et al.
Pageof 7